Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CPMD CANNAPHARMARX INC
0.014+0.001+7.69%
Close
02/03 16:00 ET
High
0.015
Open
0.015
Turnover
3.74K
Low
0.014
Pre Close
0.013
Volume
257.86K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
CannaPharmaRx Gets CRA License to Start Producing, Selling Cannabis in Canada
CannaPharmaRx Receives Cultivation License From Health Canada and Projects 2023 Revenue Over $30 Million
CALGARY, AB, Dec. 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- CannaPharmaRx, Inc. (OTC PINK:CPMD)(the "Company"), an emerging leader in development and operation of ultramodern, highly efficie
CannaPharmaRx Gets Health Canada Cultivation License, Co Sees Annual Sales of $30M
CannaPharmaRx Files Response With Health Canada in Preparation for Cremona Facility Opening
CALGARY, AB / ACCESSWIRE / September 7, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that on August 31 th
CannaPharmaRx Inks Cannabis Supply Contract With Israel's Spring Medical
CannaPharmaRx (OTCPK:CPMD) signed an agreement with Israeli company Spring Medical Group for commercial cannabis. Under the agreement CannaPharmaRx will cultivate commercial cannabis at its Cremona Fa
CannaPharmaRx Signs Collaboration and Offtake Agreement With Spring Medical Group for Up to $12 Million of Commercial Cannabis
CALGARY, AB / ACCESSWIRE / August 24, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a M
CannaPharmaRx enters into a genetics transfer agreement with High Profile Cannabis
CannaPharmaRx (OTCPK:CPMD) on Wednesday signed a genetics transfer agreement with Canadian cannabis company High Profile Cannabis. As per the deal, High Profile will deliver live cannabis plants and s
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp.
CALGARY, AB / ACCESSWIRE / June 29, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a gen
Is Cannabis Stock Cannapharmarx Inc (CPMD) in the Bottom of the Drug Manufacturers - Specialty & Generic Industry Thursday?
Cannabis stock Cannapharmarx Inc is higher by 11.2% Thursday. Cannapharmarx Inc (CPMD) is near the bottom in its industry group according to InvestorsObserver. CPMD gets an overall rating of 7. That means it scores higher than 7 percent of stocks. Cannap
Pot Stock Surges 16.28% Tuesday: Should You Buy Cannapharmarx Inc (CPMD)?
CPMD, a player in the cannabis market, is higher by 16.28% Tuesday as it outperforms the market as a whole. Cannapharmarx Inc (CPMD) is near the bottom in its sector according to InvestorsObserver. CPMD gets an overall rating of 2. That means it scores
Company Overview
More
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. It focuses on the treatment of disease states such as neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders, and ophthalmology. The company was founded in August 1998 and is headquartered in Calgary, Canada.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet